The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study of TAS-102 in combination with oxaliplatin (TAS-OX) for refractory metastatic colorectal cancer (mCRC).
 
Michael Cecchini
Honoraria - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Jeremy S. Kortmansky
No Relationships to Disclose
 
Jill Lacy
Consulting or Advisory Role - AstraZeneca; Celgene; KeyQuest Health; Navigant Consulting; Sirtex Medical
Travel, Accommodations, Expenses - Lilly
 
Neal A. Fischbach
No Relationships to Disclose
 
Jaykumar Ranchodbhai Thumar
No Relationships to Disclose
 
Kert D. Sabbath
Stock and Other Ownership Interests - Celgene; Johnson & Johnson
Speakers' Bureau - Takeda
 
Christina M. Gomez
No Relationships to Disclose
 
Jonathan Sporn
No Relationships to Disclose
 
Stacey Stein
Consulting or Advisory Role - Eisai; Genentech/Roche; Merck
 
Howard S. Hochster
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Sirtex Medical